Zohar Yehoshua

Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies.

Beatrice Uziely, Susan Jeffers, Rut Isacson et al. · Journal of Clinical Oncology · 1995 · 476 citations

Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials

Jeffrey S. Heier, Eleonora M. Lad, Frank G. Holz et al. · The Lancet · 2023 · 372 citations

Ocular Disease, Ophthalmology, Age-related Diseases +4

Systemic Complement Inhibition with Eculizumab for Geographic Atrophy in Age-Related Macular Degeneration

Zohar Yehoshua, Carlos Alexandre de Amorim Garcia Filho, Renata Portella Nunes et al. · Ophthalmology · 2013 · 291 citations · Full text

Complement System, Ocular Disease, Autoimmune Disease +9

Progression of Geographic Atrophy in Age-Related Macular Degeneration Imaged with Spectral Domain Optical Coherence Tomography

Zohar Yehoshua, Philip J. Rosenfeld, Giovanni Gregori et al. · Ophthalmology · 2010 · 274 citations · Full text

Ocular Disease, Ophthalmology, Age-related Diseases +4

PHARMACOKINETIC RATIONALE FOR DOSING EVERY 2 WEEKS VERSUS 4 WEEKS WITH INTRAVITREAL RANIBIZUMAB, BEVACIZUMAB, AND AFLIBERCEPT (VASCULAR ENDOTHELIAL GROWTH FACTOR TRAP-EYE)

Michael W. Stewart, Philip J. Rosenfeld, Fernando M. Penha et al. · Retina · 2011 · 225 citations · Full text